Francis Chris's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Oct 18, 2024
- Accession no.
- 0000950170-24-115726
- Filed
- Oct 18, 2024
- Trade date
- Oct 16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.86M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Francis ChrisCIK 0001657709 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 | Ordinary Shares | SSaleDisposed | −79,714 | $14.00 | −$1,115,996 | 0 | Direct | |
| Oct 16, 2024 | Ordinary Shares | MOption exerciseAcquired | +40,997 | $2.48 | +$101,672.56 | 40,997 | Direct | |
| Oct 16, 2024 | Ordinary Shares | SSaleDisposed | −40,997 | $13.00 | −$532,961 | 0 | Direct | |
| Oct 16, 2024 | Ordinary Shares | MOption exerciseAcquired | +65,625 | $3.14 | +$206,062.5 | 65,625 | Direct | |
| Oct 16, 2024 | Ordinary Shares | SSaleDisposed | −65,625 | $13.75 | −$902,343.75 | 0 | Direct | |
| Oct 16, 2024 | Ordinary Shares | MOption exerciseAcquired | +22,500 | $2.83 | +$63,675 | 22,500 | Direct | |
| Oct 16, 2024 | Ordinary Shares | SSaleDisposed | −22,500 | $13.50 | −$303,750 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 | Ordinary Shares | MOption exerciseDisposed | −40,997 | $0.00 | $0 | 0 | Direct | |
| Oct 16, 2024 | Ordinary Shares | MOption exerciseDisposed | −65,625 | $0.00 | $0 | 84,375 | Direct | |
| Oct 16, 2024 | Ordinary Shares | MOption exerciseDisposed | −22,500 | $0.00 | $0 | 22,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.